昂利康：11月24日召开董事会会议

Group 1 - The core point of the article is that Anglikon (SZ 002940) held its 14th meeting of the 4th board of directors on November 24, 2025, to discuss the election of a director for company affairs [1] - For the first half of 2025, Anglikon's revenue composition is entirely from the pharmaceutical manufacturing industry, accounting for 100.0% [1] - As of the report date, Anglikon's market capitalization is 7.9 billion yuan [1] Group 2 - The article also mentions that Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a floating profit of 24.92 million yuan for the actual controller and his brother [1]